2022
DOI: 10.1007/s40495-021-00280-7
|View full text |Cite
|
Sign up to set email alerts
|

Role of Pharmacogenomics in Reducing the Risk of Drug-Related Iatrogenesis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(4 citation statements)
references
References 211 publications
0
4
0
Order By: Relevance
“…Drug induced hepatic damage is the major cause of iatrogenic disease. [69] Hepatic damage is exacerbated by oxidative stress and free radicals, which can be mitigated by the antioxidant mechanism. Plant extracts are a good source of antioxidants and can help with hepatoprotection.…”
Section: Hepato-protective Activitymentioning
confidence: 99%
See 1 more Smart Citation
“…Drug induced hepatic damage is the major cause of iatrogenic disease. [69] Hepatic damage is exacerbated by oxidative stress and free radicals, which can be mitigated by the antioxidant mechanism. Plant extracts are a good source of antioxidants and can help with hepatoprotection.…”
Section: Hepato-protective Activitymentioning
confidence: 99%
“…The liver plays a significant role in metabolic homeostasis of the body, storage, secretion and detoxification of exogenous and endogenous substances, including various pharmaceutical and environmental chemicals. Drug induced hepatic damage is the major cause of iatrogenic disease [69] . Hepatic damage is exacerbated by oxidative stress and free radicals, which can be mitigated by the antioxidant mechanism.…”
Section: Biological Properties Of S Cumini Leavesmentioning
confidence: 99%
“…As the population continues to age, the use of multiple medications is increasing at an alarming rate, with some reports showing an average of 14 or more prescriptions being taken by adults ≥50 years of age [ 1 , 2 ]. The comorbidities that increase with aging often necessitate polypharmacy, which increases drug-related iatrogenesis for a population that is at high risk for health problems [ 1 , 3 ]. Pharmacogenomics (PGx) assists in reducing medication-related iatrogenesis and optimizing medication regimens by identifying genomic variants known to impact drug disposition and response [ 3 , 4 ].…”
Section: Introductionmentioning
confidence: 99%
“…The comorbidities that increase with aging often necessitate polypharmacy, which increases drug-related iatrogenesis for a population that is at high risk for health problems [ 1 , 3 ]. Pharmacogenomics (PGx) assists in reducing medication-related iatrogenesis and optimizing medication regimens by identifying genomic variants known to impact drug disposition and response [ 3 , 4 ]. Clinicians can use PGx test results to guide dose/drug selection, along with consideration of other patient-specific factors (e.g., age, comorbidities, concomitant medications) [ 4 ].…”
Section: Introductionmentioning
confidence: 99%